Analysis of somatostatin receptor subtype mRNA expression in human breast cancer

British Journal of Cancer

Volumn 75, Issue 6, 1997, Pages 798-803

  Evans, A A ^a,b   Crook, T ^a   Laws, Sam ^a   Gough, A C ^a   Royle, G T ^a   Primrose, J N ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Somatostatin; Somatostatin receptor

Indexed keywords

MESSENGER RNA; RECEPTOR SUBTYPE; SOMATOSTATIN RECEPTOR;

ARTICLE; AXILLARY LYMPH NODE; BREAST; BREAST CANCER; BREAST CARCINOMA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; PRIORITY JOURNAL; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROBE;

EID: 0031049964     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.143     Document Type: Article

References (37)

1. Buscail L, Delesque N, Esteve J, Saint-Laurent N, Prats II, Clerc P, Robberecht P, Bell G, Liebow C, Schally A, Vaysse N and Susini C (1994) Stimulation of Tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc Natl Acad Sei USA 91: 2315-2319
2. Buscail L, Esteve J, Saint-Laurent N, Bertrand V, Reisine T, O'CarroIl A, Bell G, Schally A, Vaysse N and Susini C (1995) Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc Nail Acad Sei USA 92: 1580-1584
3. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
4. Eden P and Taylor J (1993) Somatostatin receptor subtype gene expression in human and rodent tumors. Life Sei 53: 85-90
5. Furlanetto R and Dicarlo J (1984) Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture. Cancer Res 44: 2122-2128
6. Ghirlanda G, Uccioli L, Perri F, Altomonte L, Bertoli A, Manna R, Frati L and Greco A (1983) Epidermal growth factor, somatostatin and psoriasis. Lancet 1 65
7. Hofland L, Visser-Wisselaar H and Lamberts S (1995) Somatostatin analogs: clinical application in relation to human somatostatin receptor subtypes. Biochem Pharmacol 50: 287-297
8. Hoyer D, Lubbert H and Bruns C (1994) Molecular pharmacology of somatostatin receptors. Naitnyn-Schmiedebcrg's Arch Pharmacol350: 441-453
9. Huynh H and Pollack M (1994) Enhancement of tamoxifen-induced suppression of insulin-like growth factor 1 gene expression and serum level by a somatostatin analogue. Biochem Biophys Res Commun 203: 253-259
10. Krenning E, Kwekkeboom D, Reubi J, Van Hagen P. Van Eijck C, Oei H and Lamberts S (1993) 'In-octreotide scintigraphy in oncology. Digestion 54 (Suppl. 1): 84-87
11. Liebow C, Reilly C, Serrano M and Schally A (19S9) Somatostatin analogues inhibit grow th of pancreatic cancer by stimulating tyrosine phosphatase. Proc Nail Acad Sei USA 86: 2003-2007
12. Kneuchi S, Nishizawa Y, Motomura K, Inaji H, Imaoka S, Koyama H and Matsumoto K (1993) Inhibitory effect of a somatostatin analogue (SMS 201-995) on the growth of androgen dependent mouse mammary tumor (Shionogi carcinoma). Jpn J Cancer Res 84: 656-663
13. O'carroll A, Raynor K, Lolait S and Reseine T (1994) Characterisation of cloned human somatostatin receptor SSTR5. Mol Pharmacol 46: 291-298
14. Papotti M, Macri L, Bussolati G and Reubi J (1989) Correlative study on neuroendocrine differentiation and presence of somatostatin receptors in breast carcinomas. In! J Cancer 43: 365-369
15. Patel Y, Greenwood M, Warszynska A, Panetta R and Srikant C (1994) All five cloned human somatostatin receptors (hSSTRI-5) are functionally coupled to adenyl cyclase. Biochem Biophys Res Commun 198: 605-612
16. Pollack M, Polychronakos C and Guyda H (1989) Somatostatin analogue SMS 201-995 reduces serum IGF-I levels in patients with neoplasmas potentially dependent on IGF-1. Anticancer Res 9: 889-892
17. Prévost G, Provost P, Salle V, Lanson M and Thomas F (1993) A cross-linking assay allows the detection of receptors for the somatostatin analogue lanreotide in human breast tumours. Ear J Cancer 29A: 1589-1592
18. Reichlin S (19S3a) Somatostatin. N Engl J hied 309: 1495-1501
19. Reichlin S (19836) Somatostatin. N Eng! J Med 309: 1536-1563
20. Reubi J and Torhorst J (1989) The relationship between somatostatin, epidermal growth factor and steroid hormone receptors in breast cancer. Cancer, 64, 1254-1260.
21. Reubi J, Waser B, Foekens J, Klijn J, Lamberts S and Laissue J (1990) Somatostatin receptor incidence and distribution in breast cancer using receptor autoradiography: relationship to EOF receptors. Int J Cancer 46:416-420
22. Reubi J, Schaer J, Waser B and Mengod G (1994) Expression and localisation of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in-siiu hybridisation. Cancer Res 54: 3455-3459
23. Rohrer L, Raulf F, Bruns C, Buettner R, Hofstaedter F and Schule R (1993) Cloning and characterisation of a fourth human somatostatin receptor. Proc Natl Acad Sei USA 90: 4196-4200
24. Rose D, Gottardis M and Noonan J (1983) Rat mammary carcinoma regressions during suppression of serum growth hormone and prolactin. Aniicancer Res 3: 323-326
25. Scambia G, Panici P, Baiocchi G, Perrone L, lacobelli S and Mancuso S (1988) Antiproliferative effects of somatostatin and the somatostatin analog SMS 201-995 on three human breast cancer cell lines. J Cancer Res Clin Oncol 114: 306-308
26. Schally A, Cai R, Torres-Aleman I, Redding T, Szoke B, Fu D, Hierowski M, Colaluca J and Konturek S (1986) Endocrine, gastrointestinal and antitumor activity of somatostatin analogues. In Neural and Endocrine Peptides and Receptors, Moody T (ed.), pp. 73-88. Plenum: New York
27. Schally A (1988) Oncological applications of somaiostalin analogues. Cancer Res 48: 6977-6985
28. Serrano M, Hannon G and Beach D (1993) A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707
29. Setyono-Han B, Henkelman M. Foekens J and Klijn J (1987) Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells. Cancer Res 47: 1566-1570
30. Szende B, Lapis K, Redding T, Srkalovic G and Schally A ( 1989) Growth inhibition of MXT mammary carcinoma by enhancing programmed cell death (apoptosis) with analogs of LH-RH and somatostatin. Breast Cancer Res Treat 14: 307-314
31. Van Eijck C, Krenning E, Bootsma A, Oei H, Van Pel R, Lindemans J, Jeekel J, Reubi J and Lamberts S (1994) Somatostatin-receptor scintigraphy in primary breast cancer. Lancet 343:640-643
32. Weber C, Merriam L, Koschitzky T, Karp F, Benson M, Förde K and Logerfo P (1989) Inhibition of growth of human breast carcinomas in vivo by somatostatin analog SMS 201-995: treatment of nude mouse xenografts. Surgery 106:416-422
33. Weckbecker G, Tolcsvai L, Stoltz B, Pollack M and Bruns C (1994) Somatostatin analogue octreolide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7, 12-dimethylbenz(fl)anthracene-induced rat mammary carcinomas. Cancer Res 54: 6334-6337
34. Weltering E, Barrie R, O'dorisio T, Arce D, Ure T, Cramer A, Holmes D, Robertson J and Fassler J (1990) Somatostatin analogues inhibit angiogencsis in the chick chorioallantoic membrane. Digestion 46(suppl. 1): 123
35. Yamada Y, Post S, Wang K, Tager H, Bell G and Seino S (1992) Cloning and functional characterisation of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract and kidney. Proc Natl Acad Sei USA S9: 251-255
36. Yamada Y, Reisine T, Law S, Ihara Y, Kubota A, Kagimoto S, Seino M, Bell G and Seino S (19926) Somatostatin receptors, an expanding gene family: cloning and functional characterisation of human SSTR3, a protein coupled to adcnyl cyclase. Mol Endocrinol 6: 2136-2142
37. Yamada Y, Kagimoto S, Kubota A, Yasuda K, Masuda K, Someya Y, Ihara Y, Li Q, Imura H, Seino S and Seino Y (1993) Cloning, functional expression and pharmacological characterisation of a fourth (hSSTR4) and a fifth (hSSTRS) human somatostatin receptor subtype. Biochem Biophys Res Commun 195: 844-852